CD96 and acute myeloid leukemia: These checkpoint proteins have additive antitumor effects, and CD96 plays an important role in immune response (34); azacytidine and decitabine have become inhibitors of DNA methylation combined with chemotherapeutic drugs, which can prolong the survival time of AML patients and improve the prognosis of AML patients (22).